Adili Reheman
Overview
Explore the profile of Adili Reheman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
707
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fedorov K, Jankowski A, Sheikh S, Blaszykowski C, Reheman A, Romaschin A, et al.
J Mater Chem B
. 2020 Apr;
3(44):8623-8628.
PMID: 32262718
Much biomedical equipment consisting of or containing plastic polymer(s) must come into contact with blood - an interaction that, at the molecular level, may unfortunately prompt biological processes with potentially...
2.
Cameron-Vendrig A, Reheman A, Siraj M, Xu X, Wang Y, Lei X, et al.
Diabetes
. 2016 Mar;
65(6):1714-23.
PMID: 26936963
Short-term studies in subjects with diabetes receiving glucagon-like peptide 1 (GLP-1)-targeted therapies have suggested a reduced number of cardiovascular events. The mechanisms underlying this unexpectedly rapid effect are not known....
3.
4.
Eltringham-Smith L, Lei X, Reheman A, Lambourne M, Pryzdial E, Ni H, et al.
Transfusion
. 2014 Nov;
55(5):1040-50.
PMID: 25403994
Background: The evidence supporting plasma transfusion as a means to restore hemostatic control and prevent or treat bleeding is weak, leading to uncertainties as to which proteins affect the therapeutic...
5.
Wang Y, Reheman A, Spring C, Kalantari J, Marshall A, Wolberg A, et al.
J Clin Invest
. 2014 Sep;
124(10):4281-93.
PMID: 25180602
Plasma fibronectin (pFn) has long been suspected to be involved in hemostasis; however, direct evidence has been lacking. Here, we demonstrated that pFn is vital to control bleeding in fibrinogen-deficient...
6.
Reheman A, Xu X, Reddy E, Ni H
Circ Res
. 2014 Mar;
114(7):1070-3.
PMID: 24677231
No abstract available.
7.
Fedorov K, Blaszykowski C, Sheikh S, Reheman A, Romaschin A, Ni H, et al.
Langmuir
. 2014 Mar;
30(11):3217-22.
PMID: 24625256
In contemporary society, a large percentage of medical equipment coming in contact with blood is manufactured from plastic polymers. Unfortunately, exposure may result in undesirable protein-material interactions that can potentially...
8.
Lei X, Reheman A, Hou Y, Zhou H, Wang Y, Marshall A, et al.
Thromb Haemost
. 2013 Nov;
111(2):279-89.
PMID: 24172860
Platelet adhesion and aggregation at the sites of vascular injury are key events for thrombosis and haemostasis. It has been well demonstrated that interaction between glycoprotein (GP) Ibα and von...
9.
Murphy A, Bijl N, Yvan-Charvet L, Welch C, Bhagwat N, Reheman A, et al.
Nat Med
. 2013 Apr;
19(5):586-94.
PMID: 23584088
Platelets have a key role in atherogenesis and its complications. Both hypercholesterolemia and increased platelet production promote atherothrombosis; however, a potential link between altered cholesterol homeostasis and platelet production has...
10.
Wang Y, Andrews M, Yang Y, Lang S, Jin J, Cameron-Vendrig A, et al.
Cardiovasc Hematol Disord Drug Targets
. 2012 Oct;
12(2):126-32.
PMID: 23030445
Platelets are small anucleate cells generated from megakaryocytes in the bone marrow. After being released into the circulation, platelets play key roles in the surveillance of vascular injury, and can...